Lipid peroxidation early after brain injury

Journal of Neurotrauma

Volumn 21, Issue 6, 2004, Pages 667-677

  Scholpp, Joachim ^a,c   Schubert, Jochen K ^b   Miekisch, Wolfram ^b   Noeldge Schomburg, Gabriele F E ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^c NONE   (Germany)

Author keywords

Brain injury; Clinical trials; Lipid peroxidation; Malondialdehyde; n pentane; Neuroprotection; Thiobarbituric acid reactive substances

Indexed keywords

BIOCHEMICAL MARKER; MALONALDEHYDE; PENTANE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; AGED; ARTICLE; BRAIN EDEMA; BRAIN INJURY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DEVELOPING COUNTRY; DIAGNOSTIC VALUE; DISEASE COURSE; EARLY DIAGNOSIS; FEMALE; GAS EXCHANGE; HEAD INJURY; HUMAN; HUMAN EXPERIMENT; LIPID PEROXIDATION; MALE; NEUROPROTECTION; NORMAL HUMAN; SUBARACHNOID HEMORRHAGE;

ACUTE-PHASE REACTION; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BRAIN INJURIES; CASE-CONTROL STUDIES; FEMALE; HUMANS; INTERMITTENT POSITIVE-PRESSURE VENTILATION; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MIDDLE AGED; PENTANES; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TIME FACTORS;

EID: 3042813303     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/0897715041269632     Document Type: Article

References (56)

1. ABOU-SEIF, M.A., and YOUSSEF, A.A. (2001). Oxidative stress and male IGF-1, gonadotropin and related hormones in diabetic patients. Clin. Chem. Lab. Med. 39, 618-621.
2. AGARDH, C.D., ZHANG, H., SMITH, M.L., et al. (1991). Free radical production and ischemic brain damage: influence of postischemic oxygen tension. Int. J. Dev. Neurosci. 9, 127-138.
3. ANDREONI, K.A., KAZUI, M., CAMERON, D.E., et al. (1999). Ethane: a marker of lipid peroxidation during cardiopulmonary bypass in humans. Free Radic. Biol. Med. 26, 439-445.
4. ARMSTRONG, D., and BROWNE, R. (1994). The analysis of free radicals, lipid peroxides, anti-oxidant enzymes and compounds related to oxidative stress as applied to the clinical chemistry laboratory. Free Radic. Diagn. Med. 46, 366.
5. ARMSTRONG, D. (1998). In vitro screening for anti-oxidant activity. Free Radic. Antioxid. Prot. 108, 315-324.
6. ARNALICH, F., HERNANZ, A., LOPEZ-MADERUELO, D., et al. (2001). Intracellular glutathione deficiency is associated with enhanced nuclear factor-kappaB activation in older non-insulin dependent diabetic patients. Free Radic. Res. 35, 873-884.
7. BEN BAOUALI, A., AUBE, H., MAUPOIL, V., et al. (1994). Plasma lipid peroxidation in critically ill patients: importance of mechanical ventilation. Free Radic. Biol. Med. 16, 223-227.
8. BOCHICCHIO, M., LATRONICO, N., ZANI, D.G., et al. (1990). Free radical-induced lipoperoxidation and severe head injury. Intensive Care Med. 16, 444-447.
9. BURK, R.J., LUDDEN, T.M., and LANE, J.M. (1983). Pentane clearance from inspired air by the rat: dependence on the liver. Gastroenterology 84, 138-142.
10. CERNAK, I., SAVIC, V.J., KOTUR, J., et al. (2000). Characterization of plasma magnesium concentration and oxidative stress following graded traumatic brain injury in humans. J. Neurotrauma 17, 53-68.
11. CERWENKA, H., KHOSCHSORUR, G., BACHER, H., et al. (1999). Normothermic liver ischemia and antioxidant treatment during hepatic resections. Free Radic. Res. 30, 463-469.
12. CORDIS, A.G., DIPAK, K.D., and RIEDEL, W. (1998). High-performance liquid chromatographic peak identification of 2,4-dinitrophenylhydrazine derivatives of lipid peroxidation aldehydes by photodiode array detection. J. Chromatogr. A 798, 117-123.
13. DO, B.Q., HARINDER, B.S., GAREWAL, S., et al. (1996). Exhaled ethane and antioxidant vitamin supplements in active smokers. Chest 110, 159-164.
14. ELIS, A., FROOM, P., NINIO, A., et al. (2001). Employee exposure to chromium and plasma lipid peroxidation. Int. J. Occup. Environ. Health 7, 206-208.
15. EULER, D.E., DAVE, S.J., and GUO, H.S. (1996). Effect of cigarette smoking on pentane excretion in alveolar breath. Clin. Chem. 42, 303-308.
16. FRANK, H., HINTZE, T., BIMORES, D., et al. (1980). Monitoring lipid peroxidation by breath analysis: endogenous hydrocarbons and their metabolic elimination. Toxicol. Appl. Pharmacol. 56, 337-344.
17. FRANKEL, E.N. (1982). Volatile lipid oxidation products. Prog. Lipid Res. 22, 1-33.
18. FREITAS, J.P., FILIPE, P.M., and GUERRA, R.F. (1997). Lipid peroxidation in type 2 normolipidemic diabetic patients. Diabetes Res. Clin. Pract. 36, 71-75.
19. HALL, E.D., ANDRUS, P.K., YONKERS, P.A., et al. (1994). Generation and detection of hydroxyl radical following experimental head injury. Ann. N.Y. Acad. Sci. 738, 15-24.
20. HALL, E.D., BRAUGHLER, J.M., YONKERS, P.A., et al. (1991). U-78517F: a potent inhibitor of lipid peroxidation with activity in experimental brain injury and ischemia. J. Pharmacol. Exp. Ther. 258, 688-694.
21. HALL, E.D. (1995). Inhibition of lipid peroxidation in central nervous system trauma and ischemia. J. Neurol. Sci. 134, 79-83.
22. HSIANG, J.N.K., WANG, J.Y., IP, S.-M., et al. (1997). The time course and regional variations of lipid peroxidation after diffuse brain injury in rats. Acta Neurochir. (Wien) 139, 464-468.
23. HULTQVIST, M., HEGBRANT, J., NILSSON-THORELL, C., et al. (1997). Plasma concentrations of vitamin C, vitamin E and/or malondialdehyde as markers of oxygen free radical production during hemodialysis. Clin. Nephrol. 47, 37-46.
24. JANERO, D.R. (1990). Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic. Biol. Med. 9, 515-540.
25. KARAKUECUEK, E.I., PASAOGLU, H., PASAOGLU, A., et al. (1997). Endogenous neuropeptides in patients with acute traumatic head injury II: changes in the levels of cerebrospinal fluid substance P, serotonin and lipid peroxidation products in patients with head trauma. Neuropeptides 31, 259-263.
26. KASPRZAK, H.A., WOZNIAK, A., DREWA, G., et al. (2001). Enhanced lipid peroxidation processes in patients after brain contusion. J. Neurotrauma 18, 793-797.
27. KAZUI, M., ANDREONI, K.A., NORRIS, E.J., et al. (1992). Breath ethane: A specific indicator of free-radical-mediated lipid peroxidation following reperfusion of the ischemic liver. Free Radic. Biol. Med. 13, 509-515.
28. KHARITONOV, S.A., and BARNES, P.J. (2001). Exhaled markers of pulmonary disease. Am. J. Respir. Crit. Care Med. 163, 1693-1722.
29. KNEEPKENS, C.M.F., LEPAGE, G., and ROY, C.C. (1994). The potential of the hydrocarbon breath test as a measure of lipid peroxidation. Free Radic. Biol. Med. 17, 127-160.
30. KNUTSON, M.D., LIM, A.K., and VITERI, F.E. (1999). A practical and reliable method for measuring ethane and pentane in expired air from humans. Free Radic. Biol. Med. 27, 560-571.
31. KOHLMUELLER, D., and KOCHEN, W. (1993). Is n-pentane really an index of lipid peroxidation in humans and animals? A methodological reevaluation. Anal. Biochem. 210, 268-276.
32. LAPENNA, D., CIOFANI, G., PIERDOMENICO, G., et al. (2001). Reaction conditions affecting the relationship between thiobarbituric acid reactivity and lipid peroxides in human plasma. Free Radic. Biol. Med. 31, 331-335.
33. LEPAGE, G., and ROY, C.C. (1986). Direct transesterification of all classes of lipids in a one-step reaction. J. Lipid. Res. 27, 114-120.
34. MAAS, A.I.R. (2001). Neuroprotective agents in traumatic brain injury. Exp. Opin. Invest. Drugs 10, 753-767.
35. MARSHALL, L.F., MAAS, A.I.R., BOWERS MARSHALL, S., et al. (1998). A multicenter trial on the efficacy of using tirilazad mesylate in cases of head injury. J. Neurosurg. 89, 519-525.
36. MENDIS, S., SOBOTKA, P.A., and EULER, D.E. (1994). Pentane and isoprene in expired air from humans: gas-chromatographic analysis of single breath. Clin. Chem. 40, 1485-1488.
37. MENDIS, S., SOBOTKA, P.A., LEJA, F.L., et al. (1995). Breath pentane and plasma lipid peroxides in ischemic heart disease. Free Radic. Biol. Med. 19, 679-684.
38. MEZZETTI, A., CIPOLLONE, F., and CUCCURULLO, F. (2000). Oxidative stress and cardiovascular complications in diabetes: Isoprostanes as a new marker on an old paradigm. Cardiovasc. Res. 47, 475-488.
39. MIEKISCH, W., SCHUBERT, J., MUELLER, W.P.E., et al. (1999). Analysis of exhaled air as a new means of critical care testing, in: Advances in Critical Care Testing. W.S. List, M.M. Muller, and A.S. John (eds), AVL: Schaffhausen, pps. 202-211.
40. MORITA, S., SNIDER, M.T., and INADA, Y. (1986). Increased n-pentane excretion in humans: a consequence of pulmonary oxygen exposure. Anesthesiology 64, 730-733.
41. MUELLER, W., SCHUBERT, J., BENZING, A., et al. (1998). Method for analysis of exhaled air by microwave energy desorption coupled with gas chromatography-flame ionization detection-mass spectrometry. J. Chromatogr. B 716, 27-38.
42. NAVEAU, S., ABELLA, A., RAYNARD, B., et al. (2001). Tumor necrosis factor soluble receptor p55 and lipid peroxidation in patients with acute alcoholic hepatitis. Am. J. Gastroenterol. 96, 3361-3367.
43. OLOPADE, C.O., CRISTON, J.A., ZAKKAR, M., et al. (1997). Exhaled pentane and nitric oxide levels in patients with obstructive sleep apnea. Chest 111, 1500-1504.
44. PHILLIPS, M., and GREENBERG, J. (1991). Method for the collection and analysis of volatile compounds in the breath. J. Chromatogr. 564, 242-249.
45. PHILLIPS, M., SABA, M., and GREENBERG, J. (1994). Increased pentane and carbon disulfide in the breath of patients with schizophrenia. Clin. Pathol. 46, 861-864.
46. RISBY, T.H., and SEHNERT, S.S. (1999). Clinical application of breath biomarkers of oxidative stress status. Free Radic. Biol. Med. 27, 1182-1192.
47. ROOF, R.L., and HALL, E.D. (2000). Gender differences in acute CNS trauma and stroke: neuroprotective effects of estrogen and progesterone. J. Neurotrauma 17, 367-388.
48. SCHISTERMAN, E.F., FARAGGI, D., BROWNE, R., et al. (2001). TBARS and cardiovascular disease in a population based sample. J. Cardiovasc. Risk 8, 219-222.
49. SCHOLPP, J., SCHUBERT, J.K., MIEKISCH, W., et al. (2002). Breath markers and soluble lipid peroxidation markers in critically ill patients. Clin. Chem. Lab. Med. 40, 587-594.
50. SCHUBERT, J.K., MUELLER, W.P.E., BENZING, A., et al. (1998). Application af a new method for analysis of exhaled gas in critically ill patients. Intensive Care Med. 24, 415-421.
51. SIU, G.M., and DRAPER, H.H. (1982). Metabolism of malondialdehyde in vivo and in vitro. Lipids 17, 349-355.
52. SMITH, S.L., ANDRUS, P.K., ZHANG, J.-R., et al. (1994). Direct measurement of hydroxyl radicals, lipid peroxidation, and blood-brain barrier disruption following unilateral cortical impact head injury in the rat. J. Neurotrauma 11, 393-404.
53. TEMPLAR, J., KON, S.P., MILLIGAN, T.P., et al. (1999). Increased plasma malondialdehyde levels in glomerular disease as determined by a fully validated HPLC method. Nephrol. Dial. Transplant. 14, 946-951.
54. VAJRAGUPTA, O., TOASAKSIRI, S., BOONYARAT, C., et al. (2000). Chroman amide and nicotinyl amide derivatives: inhibition of lipid peroxidation and protection against head trauma. Free Radic. Res. 32, 145-155.
55. WADE, C.R., and VAN RIJ, A.M. (1985). In vivo lipid peroxidation in man as measured by the respiratory excretion of ethane, pentane, and other low-molecular-weight hydrocarbons. Anal. Biochem. 150, 1-7.
56. WEIZ, Z.W., BIRNBAUM, A.J., SOBOTKA, P.A., et al. (1991). High breath pentane concentrations during acute myocardial infarction. Lancet 337, 933-935.